#healthcare-regulation

#healthcare-regulation

Fluoride-containing toothpaste for children is under scrutiny due to potential harm if ingested, prompting lawsuits against major brands.

HHS proposes HIPAA updates to strengthen cybersecurity and eliminate distinction between required and addressable rules.

Metabolic medicine dominated life sciences in 2024, driven by weight loss drugs and new market entrants.

Plasma donation in northeastern Hungary reflects economic desperation, especially among marginalized populations, becoming a survival strategy amidst chronic unemployment.

New FDA guidelines mandate clearer communication of drug risks in advertising, focusing on simplicity and transparency.

Nursing home ownership is consolidating among large corporate groups, posing risks to care quality and residents' wellbeing.

The regulation of nursing homes has significantly improved quality of care over the past 15 years.

Legislation aims to protect patient care by limiting private equity influence over healthcare decisions, despite concerns about investment deterrents.

New regulations aim to improve access to affordable mental health services for 175 million Americans with private health insurance.

The Peruvian government classified transgender identity as a mental health problem, sparking outrage among the LGBTQ community.

Doctors in Texas may face added requirements when performing abortions, potentially discouraging them from providing necessary care.

The Department of Health and Human Services is reinforcing the need for written, informed consent for sensitive medical examinations in training institutions.

The U.S. Supreme Court justices did not appear ready to limit access to the abortion pill mifepristone, which has significant implications.

The FDA approved mifepristone in 2000 as a safe way to end early pregnancies, and the agency has monitored its safety for more than 20 years.